Cancer Prevention and Research Institute of Texas Awards $7.5 Million to Baylor Scott & White Research Institute

Baylor Scott & White Research Institute will establish the Texas site of the Connect for Cancer Prevention StudyTM (Connect), a project of the National Cancer Institute (NCI), part of the National Institutes of Health. Nine healthcare systems plan to enroll 200,000 adults across the U.S.

Precision medicine navigators increase genomic testing rates for Black patients with prostate cancer

The presence of a clinical navigator to act as a liaison between people with prostate cancer and the health care system greatly increases the likelihood that patients, especially Black patients, will receive advanced testing that can help predict the severity of their disease and guide treatment, a new study suggests.

Most Non-English Speakers in the U.S. Are Turned Away Before Their First Cancer Visit According to New Research in JNCCN

New study in JNCCN from the University of Michigan found English speakers who call a hospital general information line were able to get information on next steps to access cancer care 94% of the time, compared to 38% for Spanish speakers and just 28% for Mandarin speakers.

ASCO23: Sylvester Cancer Experts Available for Interviews on a Wide Range of Topics

In addition to presenting Sylvester Comprehensive Cancer Center research findings, Sylvester experts are available at ASCO to share perspectives on a wide variety of topics and studies ranging from breast cancer to sarcoma, prostate cancer, mesothelioma, melanoma, CNS tumors and more.

Wake Forest University School of Medicine Receives $2.7 Million Grant from National Cancer Institute to Study Lung Cancer Disparities

Wake Forest University School of Medicine has been awarded a five-year, $2.7 million grant from the National Cancer Institute to investigate lung cancer health disparities. Researchers will focus on developing novel treatments that target genetic, immunologic and metabolic changes that disproportionally affect Black patients with non-small cell lung cancer (NSCLC).

Cedars-Sinai Launches New Division of Population Sciences Research

The Cedars-Sinai Department of Biomedical Sciences has established a new division that is charged with developing a deeper understanding of the impact of social, behavioral and environmental risk factors on human diseases.

American Cancer Society Releases Latest Cancer Statistics, Launches Initiative to Address Prostate Cancer Resurgence and Disparities

Today, the American Cancer Society released Cancer Statistics, 2023, the organization’s annual report on cancer facts and trends. According to the report, overall cancer mortality has dropped 33% since 1991, averting an estimated 3.8 million cancer deaths. Based on ACS data, in 2023 there are projected to be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States.

New Study Shows Western Region has Highest Prostate Cancer Mortality Among White Men in U.S.; Black Men Face Highest Prostate Cancer Mortality Overall

New findings led by researchers at the American Cancer Society show the highest mortality rates for prostate cancer in White men were found in the Western region of the United States, including California, despite low incidence rates.

Genomic Testing Can Identify African American Prostate Cancer Patients Who Have High-Risk Disease

Moffitt Cancer Center has conducted the first prospective study to investigate genomic biomarkers associated with aggressive disease in African American men with prostate cancer. The study results were published in the Journal of the National Cancer Institute.

Mayo Clinic Cancer Center Patients, Executive Director Highlighted in American Association for Cancer Research Cancer Disparities Progress Report

The American Association for Cancer Research today released its Cancer Disparities Progress Report 2022. The publication aims to raise awareness of the enormous toll that cancer exacts on racial and ethnic minorities and other diverse and medically underserved populations in the United States while highlighting areas of recent progress in reducing cancer health disparities.

Montefiore Einstein Cancer Center Finds CAR-T Therapy Effective in Black and Hispanic Patients

CAR-T therapy, a form of immunotherapy that revs up T-cells to recognize and destroy cancer cells, has revolutionized the treatment of blood cancers, including certain leukemias, lymphomas, and most recently, multiple myeloma. However, Black and Hispanic people were largely absent from the major clinical trials that led to the U.S. Food and Drug Administration approval of CAR-T cell therapies.

Confronting Disparities in Lung Cancer

Compared with all other racial and ethnic groups in the United States, Black people are disproportionally more affected by lung cancer. Sharon R. Pine, PhD, a resident member of Rutgers Cancer Institute of New Jersey, associate professor of Pharmacology and Medicine at Rutgers Robert Wood Johnson Medical School and member of the Cancer Health Equity Center of Excellence e, discusses the barriers that Black people face, the research being done on racial health disparities and how action can be taken now.

Rutgers Cancer Institute Research: Abdominal Fat Linked to Worse Outcomes for Black Breast Cancer Survivors

Findings from a recent population based cohort study published online in JAMA Oncology show that Black women diagnosed with breast cancer who also have central obesity, which means excess body fat in the abdominal area, were more likely to die from breast cancer or any other cause than similar women who didn’t have central obesity.

Study of Cancer Patients and COVID-19 Highlights Health Disparities

Findings from a study led by researchers at Henry Ford Cancer Institute, in collaboration with Advocate Aurora Health, the Food and Drug Administration and Syapse®, show an elevated risk for severe COVID-19 effects or death among patients with cancer, with the highest risk being among low-income and Black patients.

Leading Health and Cancer Advocacy Groups Unite to Reduce Racial Disparities in Cancer Care

The National Comprehensive Cancer Network (NCCN), American Cancer Society Cancer Action Network (ACS CAN) and the National Minority Quality Forum (NMQF) presented new ideas for overcoming inequality in oncology. The recommendations address how medical systems often disproportionately fail minority patients.

MEMORIAL SLOAN KETTERING ANNOUNCES NEWLY ENDOWED CHAIR AND FELLOWSHIPS FOR HEALTH EQUITY AND DIVERSITY

The new positions reflect MSK’s commitment to expanding patient access to cancer care and supporting ongoing research aimed at reducing cancer disparities that stem from racial, ethnic, cultural, or socioeconomic barriers.

New Research in JNCCN Highlights Dangerous Disparities for Life-Saving Cancer Screening

New research in the January 2021 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds more than a third of eligible people miss timely screening tests for colorectal cancer and at least a quarter appear to miss timely screening tests for breast and cervical cancers.

Is 43 Too Young for Colon Cancer? UC San Diego Health Experts Available to Talk About Colorectal Cancer

With the recent death of actor Chadwick Boseman, many may be wondering how a seemingly healthy adult is diagnosed with a disease often thought of as illness of older adults. Although colorectal cancer is most often diagnosed in people 50…

Dr. Marcella Nunez-Smith Named Director of Center for Community Engagement and Health Equity for Yale Cancer Center and Smilow Cancer Hospital

Marcella Nunez-Smith, MD, MHS, has been appointed Director of the Center for Community Engagement and Health Equity for Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH), as well as Chief Health Equity Officer & Deputy Chief Medical Officer, at SCH, and Associate Cancer Center Director for Community Outreach and Engagement at YCC.